Macy
Macy
Macy
c
In a review by the Agency for Health Care Research and Quality, the use of preoperative GnRH
agonist was shown to decrease uterine size and increase hemoglobin. They comment about the
"lack of high-quality evidence supporting the effectiveness of most interventions for
symptomatic fibroids."23
In general, surgery is reserved for people in whom medical management has failed. Despite the
lack of good randomized evidence for the use of nonsteroidal anti-inflammatory drugs and oral
contraceptive pills, these seem to be appropriate options for properly selected women without
contraindications. Many women with fibroids, particularly those who have fibroids that are
compounding dysfunctional bleeding, can be treated successfully with a combination of
nonsteroidal anti-inflammatory drugs, birth control pills, or cyclic progestins. A short course is
reasonable for patients with fibroids before committing to surgery because some patients can be
treated successfully with medical management. Most studies of medical management are short,
from 3 months to 1 year, and long-term success remains uncertain.
Patients who are treated expectantly are usually examined more frequently than once a year. If
the myomas are large and extend laterally, consideration can be given to performing periodic
ultrasonographic studies to monitor for the development of hydronephrosis or the rare occurrence
of ureteral obstruction.
pp
j
h Fellow, Reproductive Endocrinology and Infertility,
Washington University School of Medicine
! Professor of Obstetrics and Gynecology, Tufts University
School of Medicine; Program Director, Tufts University Affiliated Hospitals OB/GYN
Residency Program; Chair, Tufts University Health Sciences Campus Institutional Review
Board; "! " Assistant Professor, Department of Obstetrics and
Gynecology, Tufts University School of Medicine; Associate Division Chief of General
Obstetrics and Gynecology, Director of Center for Abnormal Uterine Bleeding, Department of
Obstetrics and Gynecology, Tufts Medical Center
Contributor Information and Disclosures
ap V pp
ap ¢ pp
ap á p
ap
p
ap c p
ap [
p
ap ? p
ap p
ap - p
= =
[
p
p pp p
pp
p p pp p p p
pp
p pp
c
c
In general, surgery is reserved for people in whom medical management has failed. Despite the
lack of good randomized evidence for the use of nonsteroidal anti-inflammatory drugs and oral
contraceptive pills, these seem to be appropriate options for properly selected women without
contraindications. Many women with fibroids, particularly those who have fibroids that are
compounding dysfunctional bleeding, can be treated successfully with a combination of
nonsteroidal anti-inflammatory drugs, birth control pills, or cyclic progestins. A short course is
reasonable for patients with fibroids before committing to surgery because some patients can be
treated successfully with medical management. Most studies of medical management are short,
from 3 months to 1 year, and long-term success remains uncertain.
Patients who are treated expectantly are usually examined more frequently than once a year. If
the myomas are large and extend laterally, consideration can be given to performing periodic
ultrasonographic studies to monitor for the development of hydronephrosis or the rare occurrence
of ureteral obstruction.
c
A number of surgical therapies are available for the management of myomas, including
hysterectomy, abdominal myomectomy, laparoscopic myomectomy, and hysteroscopic
myomectomy. Myomas are most commonly treated with total abdominal hysterectomy. The
following sections focus on conservative surgery for leiomyomas. The traditional procedure is
abdominal myomectomy, although laparoscopic myomectomy is an acceptable option for
experienced laparoscopic surgeons.
The most recent American College of Obstetricians and Gynecologists Practice Bulletin suggests
that it "may be a safe and effective option for women with a small number of moderately sized
uterine leiomyomas who do not desire future fertility. Further studies are necessary to evaluate
the safety of this procedure for women planning pregnancy."28 However, a review of
randomized studies and clinical series concluded that laparoscopic myomectomy is feasible in
well-selected individuals and, with meticulous closure of the myometrium, is safe in women
considering pregnancy in the future.29 A randomized control trial revealed similar cumulative
pregnancy and live birth rates in women with unexplained infertility following laparoscopic
versus abdominal myomectomy.30 Laparoscopic myomectomy is gradually becoming a more
acceptable treatment for myomas.
A third technique, hysteroscopic resection, can also be used selectively for myomas impinging
on the endometrial cavity that are thought to contribute to abnormal bleeding or infertility. Over
the last 30 years, hysteroscopic resection of fibroids has become the standard for conservative
treatment for submucosal fibroids. With the recent improvements in smaller scopes, continuous
flow monitoring systems, and operative resecting tools the procedure has become safer and less
invasive and, in many cases, can be performed with minimal anesthesia and cervical
dilation. Proper patient selection and correct surgical technique are essential for optimizing
operative success and reducing risk of complications.31
Women with submucosal fibroids often have symptoms related to menorrhagia or infertility.
Most women have significant reduction in bleeding after undergoing hysteroscopic
resection. Improved fertility is also seen after removal of submucosal fibroids, although the
mechanism is not fully understood.32
#
#
Despite a long history of using myomectomy and extensive literature on this procedure, data are
actually poor because of 2 important issues related to outcome. In particular, both the recurrence
rate and the impact on fertility have been poorly studied.
p